• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Fidelity Enhanced Income Fund W-Accumulation

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Fidelity (FIL Investment SVCS (UK) Ltd)
Fund Summary The Fund's investment objective is to achieve income with the potential for some capital growth from a portfolio made up mainly of the securities of UK companies. Derivatives and forward transactions may be used for investment purposes and this may include using derivative instruments to generate additional income, for example, by the writing of call options. The Fund may also invest in other transferable securities, units in collective investment schemes, money market instruments, cash and deposits
SEDOL code B7W94N4
ISIN GB00B7W94N47
Fund code WEINA
Managers Michael Clark, David Jehan
Manager Tenure 10 years
Morningstar Category UK Equity Income
IMA Sector UK Equity Income
Fund Size £299 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.92%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.4930
Buy Price £1.4930
Price Change -1.6469%
Price Date 20th November 2019
Yield 6.41%
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 18th July 2012
Fund Status OPEN
Michael Clark joined Fidelity International in 2002 as an Equity Research Analyst. From 2002 to 2007 he covered a variety of sectors including oil services, construction and housebuilding, automotive and mining. Michael became a Portfolio Manager in 2007. Prior to joining Fidelity, Michael was an equity analyst for JP Morgan, Enskilda and Morgan Grenfell. Through these positions, he covered the engineering, consumer goods, pharmaceuticals and industrial services sectors, and now has a total of 22 year’s experience. Michael holds an MA in Modern Languages from Cambridge University.

3-year Mean Monthly Return: 0.203%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund Performance +1.58% +0.28% +3.12% +10.16% +2.48% +7.68% +13.41% +15.23% +4.24% +11.02%
Benchmark Performance
(UK Equity Income)
-0.69% +2.92% +10.10% +11.00% +3.91%
Time Period Cumulative Benchmark Performance
(UK Equity Income)
Fund Compared to Benchmark
1 day 0.46% +13.65% -13.19%
1 week 0.80% +2.14% -1.34%
1 month 2.57% +6.15% -3.58%
3 months 6.53% +3.17% +3.36%
6 months 6.23% +7.77% -1.54%
1 year 8.35% +5.32% +3.03%
3 years 3.81% +5.45% -1.64%
5 years 3.58% +8.43% -4.84%
10 years 6.84% +10.45% -3.61%
YTD 14.31% +0.52% +13.79%
Since inception 7.71% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
AstraZeneca PLC GBR 6.42%
GlaxoSmithKline PLC GBR 5.20%
BP PLC GBR 4.96%
Rio Tinto PLC GBR 4.41%
Royal Dutch Shell PLC Class A GBR 4.35%
Diageo PLC GBR 4.03%
Unilever PLC GBR 4.03%
Prudential PLC GBR 3.93%
The Royal Bank of Scotland Group PLC GBR 3.02%
SSE PLC GBR 3.01%
Dividend Date Per share amount Reinvestment Price
1st March 2019 0.0988 £1.4220
1st March 2018 0.0925 £1.3640
1st March 2017 0.0926 £1.4450
1st March 2016 0.0904 £1.3230
2nd March 2015 0.0512 £1.3300
1st December 2014 0.0136 £1.2750